https://www.pharma-marketing.com/johnson-johnson-invests-over-1-billion-in-jacksonville-vision-operations/Pharma-Marketing.comen2026-06-16T10:33:44+00:00Johnson & Johnson invests over $1 billion in Jacksonville vision operations https://www.pharma-marketing.com/de/johnson-johnson-investiert-ueber-1-milliarde-dollar-in-vision-standort-jacksonville/Pharma-Marketing.comde2026-06-16T10:33:43+00:00Johnson & Johnson investiert über 1 Milliarde Dollar in Vision-Standort Jacksonville https://www.pharma-marketing.com/gsk-to-acquire-nuvalent-in-10-6-billion-oncology-deal/Pharma-Marketing.comen2026-06-16T09:55:57+00:00GSK to acquire Nuvalent in $10.6 billion oncology deal https://www.pharma-marketing.com/de/gsk-will-nuvalent-fuer-106-milliarden-dollar-uebernehmen/Pharma-Marketing.comde2026-06-16T09:55:56+00:00GSK will Nuvalent für 10,6 Milliarden Dollar übernehmen https://www.pharma-marketing.com/germany-backs-away-from-variable-drug-discount-plan/Pharma-Marketing.comen2026-06-16T09:11:48+00:00Germany backs away from variable drug discount plan https://www.pharma-marketing.com/de/deutschland-rueckt-von-variablen-arzneirabatten-ab/Pharma-Marketing.comde2026-06-16T09:11:47+00:00Deutschland rückt von variablen Arzneirabatten ab https://www.pharma-marketing.com/kathrin-rezac-takes-over-brand-communications-at-reviderm/Pharma-Marketing.comen2026-06-16T08:54:14+00:00Kathrin Rezac takes over brand communications at Reviderm https://www.pharma-marketing.com/de/kathrin-rezac-uebernimmt-markenkommunikation-bei-reviderm/Pharma-Marketing.comde2026-06-16T08:54:13+00:00Kathrin Rezac übernimmt Markenkommunikation bei Reviderm